OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Active mechanisms of ketamine-assisted psychotherapy: A systematic review
Isak Joneborg, Yena Lee, Joshua D. Di Vincenzo, et al.
Journal of Affective Disorders (2022) Vol. 315, pp. 105-112
Closed Access | Times Cited: 29
Isak Joneborg, Yena Lee, Joshua D. Di Vincenzo, et al.
Journal of Affective Disorders (2022) Vol. 315, pp. 105-112
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Randomized trial of ketamine masked by surgical anesthesia in patients with depression
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
Nature Mental Health (2023) Vol. 1, Iss. 11, pp. 876-886
Open Access | Times Cited: 51
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
Nature Mental Health (2023) Vol. 1, Iss. 11, pp. 876-886
Open Access | Times Cited: 51
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review
Bess M. Kew, Richard Porter, Katie M. Douglas, et al.
BJPsych Open (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 34
Bess M. Kew, Richard Porter, Katie M. Douglas, et al.
BJPsych Open (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 34
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
The Production of Entheogenic Communities in the United States
Brad Stoddard
(2024)
Closed Access | Times Cited: 9
Brad Stoddard
(2024)
Closed Access | Times Cited: 9
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, et al.
Psychopharmacology (2023) Vol. 240, Iss. 7, pp. 1547-1560
Open Access | Times Cited: 18
Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, et al.
Psychopharmacology (2023) Vol. 240, Iss. 7, pp. 1547-1560
Open Access | Times Cited: 18
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 20-34
Closed Access | Times Cited: 4
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 20-34
Closed Access | Times Cited: 4
Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report
Matthew Hicks, Heather Zwickey, Ryan Bradley
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
Matthew Hicks, Heather Zwickey, Ryan Bradley
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)
Kathryn Fletcher, Nadine Ezard, Krista J. Siefried, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092504-e092504
Open Access
Kathryn Fletcher, Nadine Ezard, Krista J. Siefried, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092504-e092504
Open Access
Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample
Tyler M. Moore, Kathryn C. Walker, Elizabeth L. Tung, et al.
Journal of Affective Disorders (2025)
Closed Access
Tyler M. Moore, Kathryn C. Walker, Elizabeth L. Tung, et al.
Journal of Affective Disorders (2025)
Closed Access
Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review
Alisha M. Bruton, Dalton G. Wesemann, Taryn A. Machingo, et al.
European Child & Adolescent Psychiatry (2024) Vol. 34, Iss. 1, pp. 141-157
Closed Access | Times Cited: 3
Alisha M. Bruton, Dalton G. Wesemann, Taryn A. Machingo, et al.
European Child & Adolescent Psychiatry (2024) Vol. 34, Iss. 1, pp. 141-157
Closed Access | Times Cited: 3
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Predicting non-response to ketamine for depression: An exploratory symptom-level analysis of real-world data among military veterans
Eric A. Miller, Houtan Totonchi Afshar, Jyoti Mishra, et al.
Psychiatry Research (2024) Vol. 335, pp. 115858-115858
Open Access | Times Cited: 2
Eric A. Miller, Houtan Totonchi Afshar, Jyoti Mishra, et al.
Psychiatry Research (2024) Vol. 335, pp. 115858-115858
Open Access | Times Cited: 2
‘Mind-Revealing’ Psychedelic States: Psychological Processes in Subjective Experiences That Drive Positive Change
Rúna F. E. Walther, Hein T. van Schie
Psychoactives (2024) Vol. 3, Iss. 3, pp. 411-436
Open Access | Times Cited: 2
Rúna F. E. Walther, Hein T. van Schie
Psychoactives (2024) Vol. 3, Iss. 3, pp. 411-436
Open Access | Times Cited: 2
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review
Julia M. K. Freind, Fernando R. Beserra, Bruno S. Menezes, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 496-512
Closed Access | Times Cited: 4
Julia M. K. Freind, Fernando R. Beserra, Bruno S. Menezes, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 496-512
Closed Access | Times Cited: 4
Intravenous ketamine for treatment-resistant depression patients who have failed to respond to transcranial magnetic stimulation: A case series
Olivier Payette, Paul Lespérance, Véronique Desbeaumes Jodoin, et al.
Journal of Affective Disorders (2023) Vol. 333, pp. 18-20
Closed Access | Times Cited: 3
Olivier Payette, Paul Lespérance, Véronique Desbeaumes Jodoin, et al.
Journal of Affective Disorders (2023) Vol. 333, pp. 18-20
Closed Access | Times Cited: 3
A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy
Vivian W. L. Tsang, Dragos C. Ragazan, Pamela Kryskow, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 5, pp. 627-636
Closed Access | Times Cited: 2
Vivian W. L. Tsang, Dragos C. Ragazan, Pamela Kryskow, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 5, pp. 627-636
Closed Access | Times Cited: 2
Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder
Joshua Willms, Ben McCauley, Lindsay Kerr, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 3
Joshua Willms, Ben McCauley, Lindsay Kerr, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 3
O USO DA CETAMINA/ESCETAMINA NO TRANSTORNO DEPRESSIVO MAIOR
Juliana Celga de Mendonça, RAUL MALINI LOUVEM, BRENDA MARIA FOLLI RECLA, et al.
Editora Pasteur eBooks (2024), pp. 109-114
Open Access
Juliana Celga de Mendonça, RAUL MALINI LOUVEM, BRENDA MARIA FOLLI RECLA, et al.
Editora Pasteur eBooks (2024), pp. 109-114
Open Access
Licit use of illicit drugs for treating depression: the pill and the process
Alejandro Torrado Pacheco, Bita Moghaddam
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access
Alejandro Torrado Pacheco, Bita Moghaddam
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access
A novel framework for ketamine-assisted couple therapy
Chandra E. Khalifian, Katerine Rashkovsky, Emma Mitchell, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Chandra E. Khalifian, Katerine Rashkovsky, Emma Mitchell, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
How Do People Who Undergo Ketamine Treatment for a Psychiatric Problem Subjectively Experience This Intervention? A Meta‐Synthesis of Qualitative Studies
Melanie Trimmel, Antonia Renner, Alexander Kaltenboeck
International Journal of Mental Health Nursing (2024)
Open Access
Melanie Trimmel, Antonia Renner, Alexander Kaltenboeck
International Journal of Mental Health Nursing (2024)
Open Access
Maintenance Intramuscular Ketamine-Assisted Psychotherapy, a Retrospective Chart Review of Efficacy, Adverse Events, and Dropouts from a Community Practice
Wesley C. Ryan, Boris D. Heifets
Journal of Psychoactive Drugs (2024), pp. 1-15
Closed Access
Wesley C. Ryan, Boris D. Heifets
Journal of Psychoactive Drugs (2024), pp. 1-15
Closed Access
